Non-Invasive Lung Fluid Monitoring Using ReDS Technology to Manage Heart Failure in Primary Care A Randomized Trial

What this Trial Is About

Researchers are evaluating a heart failure management program that uses remote dielectric sensing ReDS technology to non-invasively assess lung congestion. The study aims to determine if this ReDS-guided program, led by nurses in primary care settings, can reduce urgent healthcare visits, unplanned hospitalizations for heart failure, and all-cause death. The trial also explores how well the program is implemented and identifies barriers and facilitators during its use. Participants are randomly assigned to one of two groups one receives usual care, and the other receives the ReDS-guided heart failure management program alongside usual care. This program uses ReDS technology to measure lung fluid levels and includes nurse-led algorithms for diuretic adjustments, a structured follow-up schedule, and support for self-care. The randomized controlled trial lasts 6 months with a 3-month focused follow-up for the primary outcome. During the study, participants will undergo assessments of urgent healthcare visits, hospitalizations, and survival at 3 months, along with evaluations of quality of life, self-care behavior, and healthcare costs. Measurements such as NT-proBNPBNP levels, ReDS values, and questionnaires on heart failure symptoms and health status are collected at baseline and during follow-up visits up to 6 months. The study also monitors how well the intervention is delivered and its reach among patients and healthcare providers.

Effect of Non-Invasive Lung Fluid Monitoring for Heart Failure Management in Primary Care